Qube Research & Technologies (QRT)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.24M | Buy |
229,710
+131,632
| +134% | +$4.15M | 0.01% | 1090 |
|
|
2025
Q1 | $3.21M | Buy |
98,078
+32,968
| +51% | +$1.08M | ﹤0.01% | 1379 |
|
|
2024
Q4 | $2.35M | Sell |
65,110
-35,854
| -36% | -$1.3M | ﹤0.01% | 1435 |
|
|
2024
Q3 | $3.15M | Sell |
100,964
-59,208
| -37% | -$1.85M | ﹤0.01% | 1265 |
|
|
2024
Q2 | $4.28M | Buy |
160,172
+150,569
| +1,568% | +$4.03M | 0.01% | 1095 |
|
|
2024
Q1 | $328K | Sell |
9,603
-84,722
| -90% | -$2.89M | ﹤0.01% | 2354 |
|
|
2023
Q4 | $2.73M | Buy |
+94,325
| New | +$2.73M | 0.01% | 1160 |
|
|
2023
Q3 | – | Sell |
-59,318
| Closed | -$1.78M | – | 3889 |
|
|
2023
Q2 | $1.78M | Buy |
59,318
+12,992
| +28% | +$391K | 0.01% | 1019 |
|
|
2023
Q1 | $1.68M | Buy |
46,326
+14,151
| +44% | +$513K | 0.01% | 1020 |
|
|
2022
Q4 | $1.15M | Buy |
32,175
+16,806
| +109% | +$599K | 0.01% | 1097 |
|
|
2022
Q3 | $520K | Buy |
+15,369
| New | +$520K | ﹤0.01% | 1406 |
|
|
2022
Q1 | – | Sell |
-51,750
| Closed | -$1.51M | – | 2971 |
|
|
2021
Q4 | $1.51M | Buy |
+51,750
| New | +$1.51M | 0.01% | 963 |
|
|
2020
Q3 | – | Sell |
-10,474
| Closed | -$249K | – | 2090 |
|
|
2020
Q2 | $249K | Sell |
10,474
-225
| -2% | -$5.35K | ﹤0.01% | 1362 |
|
|
2020
Q1 | $192K | Sell |
10,699
-24,563
| -70% | -$441K | 0.01% | 880 |
|
|
2019
Q4 | $836K | Buy |
+35,262
| New | +$836K | 0.03% | 690 |
|